Day: July 28, 2020

Or Yehuda, Israel, July 28, 2020 (GLOBE NEWSWIRE) — Magic Software Enterprises Ltd. (NASDAQ and TASE: MGIC), a global provider of end-to-end integration and low-code application development platforms and IT consulting services, announced today that it will report its financial results for the second quarter of 2020 on Thursday, August 13, 2020.Management will host a conference call on Thursday, August 13, 2020 at 10:00 a.m. Eastern Daylight Time (5:00 p.m. Israel Daylight Time) to review and discuss Magic’s results.Please call the following numbers (at least 5 minutes before the scheduled time) in order to participate:From North America: +1-888-668-9141From UK: 0-800-917-5108From Israel: 03-918-0609All others: +972-3-918-0609If you are unable to join live, a replay of the call will be available on the company’s website, www.magicsoftware.com.About...

VANCOUVER, British Columbia, July 28, 2020 (GLOBE NEWSWIRE) — Mission Ready Solutions Inc. (“Mission Ready” or the “Company”) (TSXV: MRS) announces that, effective August 7, 2020, James A. Marks will assume the role of interim Chief Executive Officer (“CEO”) of the Company. To facilitate this change, Jeffery L. Schwartz has tendered his resignation as the Company’s President and CEO, effective August 7, 2020, but will remain a member of the Company’s board of directors (the “Board”).Mr. Schwartz has served as the Company’s President and CEO since March 2017, during which time he has led the Company to new heights and presided over impressive revenue growth, with 2019 revenues reaching CAD $21.19 million, a 588% increase over the previous year.“We are forever grateful for Jeff’s devoted and faithful service to the Company and we...

TORONTO, July 28, 2020 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), a clinical stage company developing new drug candidates for treating organ damage caused by inflammation, today announced that it has chosen its first U.S. clinical site for the Phase II trial of its lead drug LSALT peptide (Metablok).  Broward Health Medical Center (BHMC) in Florida has agreed to participate in the trial and begin enrolling patients following internal review board approval, which is expected during the month of August.The Phase II trial will be a multicenter, randomized, double-blind, placebo-controlled, proof of concept study of LSALT peptide as prevention of organ inflammation known to trigger acute respiratory distress syndrome (ARDS) and acute kidney injury (AKI) in patients infected...

CHANDLER, Ariz., July 28, 2020 (GLOBE NEWSWIRE) — A ubiquitous Ethernet architecture simplifies the design, configuration, and control of many different applications. This is especially true for connected mobility that requires more high-speed data delivery than ever before. Automotive networks rely heavily on partial networking in which some segments are hibernated and woken up on demand. Microchip Technology Inc. (Nasdaq: MCHP), a leader in automotive Ethernet, today announced the LAN8770, an OPEN Alliance TC10 sleep standard Ethernet physical layer transceiver (PHY) with the industry’s lowest sleep current—less than 15 µA—which is around four times lower than other available devices. The LAN8770 is a compact, cost-effective, single-port 100BASE-T1 Ethernet PHY compliant with the IEEE 802.3bw-2015 specification and available in...

TUSTIN, Calif. and CARLSBAD, Calif., July 28, 2020 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, and Argonaut Manufacturing Services, a CGMP contract manufacturing organization (CMO) dedicated to providing custom manufacturing and supply chain solutions for life science, molecular diagnostics, and biopharmaceutical companies, today announced a co-marketing agreement that will provide clients an integrated manufacturing solution including process development, drug substance manufacturing, and drug product manufacturing.  Under terms of the non-exclusive agreement, the companies will...

CORONA, Calif., July 28, 2020 (GLOBE NEWSWIRE) — Monster Beverage Corporation (NASDAQ:MNST) announced today that results for its second quarter ended June 30, 2020 will be released on Tuesday, August 4, 2020 after the close of the market. The company also said that chairman and chief executive officer, Rodney Sacks, and vice chairman and president, Hilton Schlosberg, will host an investor conference call that same day at 2:00 p.m. Pacific Time to review the company’s financial results and operations.The call will be open to all interested investors through a live audio webcast via the Internet at www.monsterbevcorp.com.  For those who are not able to listen to the live broadcast, the call will be archived for approximately one year on the website.Monster Beverage CorporationBased in Corona, California, Monster Beverage Corporation...

Expanded role of Ms. Stafford as Chairman reflects the Board’s confidence in her leadership of the Company and strategic directionRenowned pharmaceutical executive Robert Ingram retiring as Executive Chair and remaining a member of Board of Directors  MORRISVILLE, N.C., July 28, 2020 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced an expanded role of Paula Brown Stafford, President and Chief Executive Officer (“CEO”) of Novan, to also include Chairman of Novan’s Board of Directors (“Board”). Concurrently, Robert Ingram is retiring as Executive Chairman and will continue as a member of the Board. These changes to the Board are effective as of today, July 28, 2020.“Since Paula’s appointment as President and CEO of Novan, she has done a tremendous job leading the Company...